News and Events

Congratulations to Sidney Gospe III, MD, PhD for receiving the Pilot Research Grant Award for his work on "Reducing neuro-inflammation in a mouse model of mitochondrial optic neuropathy". This award was announced at the annual North American Neuro-ophthalmology Society (NANOS) meeting that took place in Orlando, Florida March 2023.  

Sri Meghana Konda, MD PGY 3  and James Tian, MD  PGY4 were 2 of 10 ophthalmology residents honored with the 2023 Resident Excellence Award, presented by the American Society of Cataract and Refractive Surgery (ASCRS) Foundation. 

Leon Herndon, MD, professor of ophthalmology and glaucoma division chief was named President of the American Glaucoma Society (AGS) for 2023-2024 at the conclusion of the annual meeting held March 2-5 in Austin, Texas. Herndon has been an active member of AGS, previously serving in various leadership roles, on the board of directors, and most recently vice president from 2022-2023.

On February 17, 2023, the U.S. Food and Drug Administration (FDA) approved a groundbreaking treatment to treat geographic atrophy (GA), an advanced form of dry macular degeneration (AMD). Eleonora Lad, MD, PhD, director of clinical research and associate professor, was a lead investigator in the OAKS trial, a pivotal clinical trial that supported the FDA approval.

The Macula Society hosted it’s 46th annual meeting in Miami, Florida, February 14-18, 2023.

Eleonora Lad, MD, PhD was featured in the February cover article for AAO EyeNet magazine which focused on two novel drug therapies that are showing promise in slowi

The twenty-fifth biennial meeting of the International Society of Eye

Duke School of Medicine has received more than $527 million in federal funding from the National Institute of Health (NIH) in 2022, ranking ninth nationally, according to the Blue Ridge Institute f

Duke Eye Center faculty were among the presenters at the annual Hawaiian Eye and Retina meeting held January 14-20, 2023.  This meeting features world-class educators, practi

Duke Eye Center is participating in two pivotal gene therapy clinical trials, ATMOSPHERE and ASCENT that may become promising treatments for age-related macular degeneration.  The studies